Range
9.51 - 10
Vol / Avg.
21K/27.5K
Div / Yield
-
52 Wk
8.31 - 19.89
Mkt Cap
346.6M
Payout Ratio
-
Open
9.65
P/E
-
EPS
-0.98
Shares
35.8M
Outstanding
35.8M
Total Float
-
Benzinga - Jun 1, 2021, 5:21AM
Benzinga - Feb 16, 2021, 7:12AM
load more
Freeline Therapeutics Holdings PLC is a clinical-stage biotechnology company developing transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its lead product candidates are FLT180a for the treatment of hemophilia B, and FLT190 for the treatment of Fabry disease.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.980
REV0
FY 2020Est.ActualSurprise
EPS-2.920-6.810 -3.8900
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
FRLNFreeline Therapeutics0.52%346.6M

Freeline Therapeutics Frequently Asked Questions

Q

How do I buy Freeline Therapeutics (FRLN) stock?

A

You can purchase shares of Freeline Therapeutics (NASDAQ: FRLN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Freeline Therapeutics's (FRLN) competitors?

A

There are no as such competitors for Freeline Therapeutics.

Q

What is the target price for Freeline Therapeutics (FRLN) stock?

A

The latest price target for Freeline Therapeutics (NASDAQ: FRLN) was reported by HC Wainwright & Co. on May 19, 2021. The analyst firm set a price target for 30.00 expecting FRLN to rise to within 12 months (a possible 210.24% upside). 10 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Freeline Therapeutics (FRLN)?

A

The stock price for Freeline Therapeutics (NASDAQ: FRLN) is $9.67 last updated Fri Jun 11 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Freeline Therapeutics (FRLN) pay a dividend?

A

There are no upcoming dividends for Freeline Therapeutics.

Q

When is Freeline Therapeutics (NASDAQ:FRLN) reporting earnings?

A
Freeline Therapeutics’s Q2 earnings are confirmed for after-market on August 14, 2021.
Q

Is Freeline Therapeutics (FRLN) going to split?

A

There is no upcoming split for Freeline Therapeutics.

Q

What sector and industry does Freeline Therapeutics (FRLN) operate in?

A

Freeline Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.